![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/valuestock_image_1423.jpeg)
ResMed (NYSE:RMD) has outperformed the market over the past 5 years by 12.16% on an annualized basis producing an average annual return of 23.39%. Currently, ResMed has a market capitalization of $30.35 billion.
Buying $100 In RMD: If an investor had bought $100 of RMD stock 5 years ago, it would be worth $285.18 today based on a price of $207.47 for RMD at the time of writing.
ResMed's Performance Over Last 5 Years
![](https://www.benzinga.com/files/images/story/2022/1654189255_0.png)
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.